Outcome in Hemodialysis of Taxus Liberte

Outcome in Hemodialysis of Taxus Liberte - OUCH-TL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002594

Enrollment

120

Registered

2009-10-07

Start date

2009-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic heart disease Chronic renal failure on hemodialysis

Interventions

PCI with TAXUS Liberte stent

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patints with chronic renal failure on hemodialysis Elective PCI for Ischemic heart disease using TAXUS Liberte stent

Exclusion criteria

Exclusion criteria: CPA Cardiogenic shock Emergent PCI STEMI Intolerance with antiplatelet therapy Planned PCI for other lesions in 6 months Restenosis after DES Severe valvular heart disease Critical limb ischemia CTO No indication for PCI

Design outcomes

Primary

Measure	Time frame
Target Vessel Failure at 12 months	—

Secondary

Measure	Time frame
Binary restenosis rate by QCA Late lumen loss by QCA Death, TLR, MACE at 12 months Stent thrombosis rate Neointimal volume by IVUS Alpha 2 Macroglobulin and MACE rate Dialyzer and MACE rate or late lumen loss	—

Countries

Japan

Contacts

Public ContactHitomi Usui

Teikyo University Hospital Cardiology

PXE00364@nifty.com03-3964-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026